Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, January 27, 2015
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
NIH Researchers Tackle Thorny Side of Gene Therapy
Pre-clinical studies in mice reveal ways to reduce cancer risk with modified treatment.
Early Blood Glucose Control Lengthens Life in People with Type 1 Diabetes
Reductions in diabetes complications resulting from tight glucose control translate into longer lifespans.
Oxford Vaccine Group Begins First Trial of New Ebola Vaccine
Oxford University doctors and scientists are starting the first safety trial of an experimental preventative Ebola vaccine regimen being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen).
GRP78 Protein Possible Universal Therapeutic Target
Drug combination including Viagra is effective tool in targeting the protein.
Stem Cell Transplants May Halt Progression of Multiple Sclerosis
NIH-funded study yields encouraging early results.
Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes
Promising profile of disease modification and pain reduction leads to proof of concept trials.
Parkinson's Vaccine: EU-Team Launches Clinical Trial
Vaccine candidate based on proprietary technology by AFFiRiS AG.
Two Drugs are No More Effective Than One to Treat Common Kidney Disease
NIH study finds limited kidney benefit from more rigorous blood pressure treatment.
Gene Therapy Provides Safe, Long-Term Relief for Patients with Severe Hemophilia B
Gene therapy pioneered by St. Jude Children’s Research Hospital, University College London and the Royal Free Hospital provides men with hemophilia B reliable relief from the bleeding disorder.
Themis Bioscience’s Vaccine Against Chikungunya Successful in Phase 1
Results presented at international conferences in Philadelphia and New Orleans.
Scroll Up
Scroll Down

Balancing Leverage with Stewardship of a Corporate Compound Collection
Rose Gonzales, Pfizer Global R&D, speaking at Drug Discovery and Development 2014

Accelerate Your Research With Tecan´s New Multimode Microplate Reader Platform!
In this webinar, solutions will be presented for fast DNA quantification, single cell counting and viability analysis, and automating long-term live kinetic cell assays.

Pivot Park Screening Centre, The Pivot for Screening Knowledge and Expertise
Helma Rutjes, Pivot Park Screening Centre, speaking at Drug Discovery and Development 2014

Enabling New Pharma: Drug Re-purposing Efforts Go Mainstream. Innovative Alternatives for Stalled Pharmaceutical Pipelines
Rathnam Chaguturu, SRI International, speaking at Drug Discovery and Development 2014

Science for Life Laboratory Drug Discovery & Development Platform
Per Arvidson, Karolinska Institute, speaking at Drug Discovery and Development 2014

Characterizing the Early Drug Development Outsourcing Landscape
Stella Stergiopoulos, Tufts Center for the Study of Drug Design, speaking at Drug Discovery and Development 2014

ETP Nanomedicine and NANOMED2020: Towards a New Nanomedicine Horizon
Olivier Fontaine, Nanobiotix, speaking at Nanomedicine 2014.

TagLite® 2 cell assay - the next dimension to discovering new antibody drugs
Sandra Grau-Richards, Senior Scientist/Team Leader Roche-Glycart

Challenges of Implementing and Validating CTC Assays in Oncology Clinical Trials
Iman Jilani, Pfizer, speaking at Exosomes and Circulating Biomarkers Summit 2013.

Biomarker Development to Improve Trials for Type 1 Diabetes
Professor Matthias von Herrath, The La Jolla Institute for Allergy and Immunology, speaking at Exosomes and Circulating Biomarkers Summit 2013.

<< 1 2 3 >>
Showing Results 1 - 10 of 30
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn